Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Gastric Adenocarcinoma × disitamab vedotin × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Carcinoma, Transitional Cell 2 Rectal Neoplasms 1 Ovarian Neoplasms 1 Head and Neck Neoplasms 1 Gastric Adenocarcinoma 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

trastuzumab deruxtecan 1 taxane 1 durvalumab 1 disitamab vedotin 1 Taxes 1 Platinum 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gastrectomy 1 Cisplatin 1 Albumin-Bound Paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507526 2026-04-02

DTP-HER2

Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡